Article
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2021
Calagua Carla, Ficial Miriam, Jansen Caroline S, Hirz Taghreed, Del Balzo Luke, Wilkinson Scott, Lake Ross, Ku Anson T, Voznesensky Olga, Sykes David B, Saylor Philip J, Ye Huihui, Signoretti Sabina, Kissick Haydn, Sowalsky Adam G, Balk Steven P, Einstein David J
Abstract excerpt
PURPOSE: A subset of primary prostate cancer expresses programmed death-ligand 1 (PD-L1), but whether they have a unique tumor immune microenvironment or genomic features is unclear. EXPERIMENTAL DESIGN: We selected PD-L1-positive high-grade and/or high-risk primary prostate cancer, characterized tumor-infiltrating lymphocytes with multiplex immunofluorescence, and identified genomic alterations in immunogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
